DongKook Pharmaceutical: Overseas Cosmetics Growth Accelerates, Profitability Expected to Improve
Predicted impact: Low
Overseas cosmetics growth commentary with no specific deal size given.
DongKook Pharmaceutical동국제약
086450 · KOSDAQ · ₩086450 · 동국제약
₩23,450▼ ₩450 (1.88%)End-of-day · Oct 30, 2026 · End-of-day prices.
"DongKook Pharmaceutical growing on cosmetics"... expected to top ₩1T in annual sales this year [Why Bio]
Predicted impact: Low
Expected sales above 1 trillion won is an outlook from media; modest, vague for the stock.
Dong-Kook Pharmaceutical provides medical expense support for leg diseases of vulnerable elderly
Predicted impact: Low
Small charitable medical expense support; no meaningful financial size.
Dongkook Pharmaceutical launches 'national park hiking safety' campaign for fall foliage season
Predicted impact: Low
동국제약, 센텔리안24 창립 58주년 맞아 '기념 세트 2종' 출시
Predicted impact: Low· Actual: −9.2% vs sector, volume 1.7× normal (5 trading days)
Dongkook Pharmaceutical takes part in 'CPHI Worldwide 2026' and builds global partnerships
Predicted impact: Low· Actual: −7.2% vs sector, volume 2.0× normal (5 trading days)
Trade show participation and partnerships; no financial size disclosed, so routine news.
'Madeca' Trademark War Round 2… Dongkook Pharmaceutical Wins Partial Victory Against Aekyung Industrial
Predicted impact: Low· Actual: −1.2% vs sector, volume 1.0× normal (5 trading days)
Partial trademark court win against a small cosmetics peer; limited financial scale indicated.
동국제약 센텔리안24, 美 아마존 행사서 매출 1104% 폭증
Predicted impact: Low· Actual: +1.2% vs sector, volume 2.1× normal (5 trading days)
Amazon event sales surge of 1104% is vague with no won amount or share of revenue given.
Daehwa Pharmaceutical and Dongkook Pharmaceutical Buck Market Slump…G2GBIO Drops in Double Digits[Bio Market Check]
Predicted impact: Low· Actual: +5.0% vs sector, volume 1.2× normal (5 trading days)
Market recap reporting a double-digit drop; a price move report, not a company event.
Dongkook Pharmaceutical renames itself DK Centurion, "aiming for global expansion"
Predicted impact: Low· Actual: +13.1% vs sector, volume 2.5× normal (5 trading days)
Company renaming for global expansion; no financial impact.
Also known as: DongKook Pharmaceutical / 동국제약 / 086450 / KRX:086450
Source: KRX statistical information